Anabolic Steroids Impair the Exercise-Induced Growth of the Cardiac Capillary Bed

Background: Concomitant application of anabolic-androgenic steroids and physical exercise can induce cardiac hypertrophy. These experiments investigate the still unknown response of the cardiac myocytes and capillaries to the combined influence of various anabolic steroids and muscular exercise. Methods: Female SPF-NMRI mice were divided into the following groups: a) sedentary control, b) exercise (treadmill running); c) sedentary receiving Dianabol; d) exercise + Dianabol; e) exercise + Oral-Turinabol. After 3 and 6 weeks the left ventricular papillary muscles were studied morphometrically. Evaluated variables: minimal myocyte diameter, number of capillaries around a single myocyte, capillary density and intercapillary distance. Results: Only the anabolic steroids + exercise groups showed a mild myocyte hypertrophy. In contrast, only exercise alone caused a significant increase of the capillary density after both experimental periods; e.g. capillary density after 6 weeks (capillaries/mm², mean values ± standard deviation, p < 0.05): control (4272 ± 287), exercise (5411 ± 755), dianabol (4004 ± 333), dianabol + exercise (4076 ± 403), oral-turinabol + exercise (4053 ±306). Moreover, unlike all other regimens, only exercise alone shortened the intercapillary distance. Finally, exercise without drugs induced the greatest increase in the number of capillaries around a single myocyte. Conclusions: Anabolic steroids combined with exercise: 1) induce mild hypertrophy of the cardiac myocytes, 2) impair the cardiac microvascular adaptation to physical conditioning. The microvascular impairment may cause a detrimental alteration of the myocardial oxygen supply, especially during muscular exercise.

Heart, myocyte, hypertrophy, angiogenesis, neovascularization, capillaries, anabolic steroids, androgens, physical exercise, exercise training.

References

• 1 Anversa P, Ricci R, Olivetti G. Effects of exercise on the capillary vasculature of the rat heart.  Circulation. 1987;  75 I 12-I 18
• 2 Appell H J, Heller-Umpfenbach B, Feraudi M, Weicker H. Ultrastructural and morphometric investigations on the effects of training and administration of anabolic steroids on the myocardium of guinea pigs.  Int J Sports Med. 1983;  4 268-274
• 3 Bauman D H, Richerson J T, Britt A L. A comparison of body and organ weights, physiologic parameters, and pathologic changes in target organs of rats given combinations of exercise, anabolic hormone, and protein supplementation.  Am J Sports Med. 1988;  16 397-402
• 4 Behrendt H, Boffin H. Myocardial cell lesions caused by an anabolic hormone.  Cell Tissue Res. 1977;  181 423-426
• 5 Bhasin S, Storer T W, Berman N, Callegari C, Phillips J, Bunnell T J, Tricker R, Shirazi A, Casaburi R. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.  N Engl J Med. 1996;  335 1-7
• 6 Breisch E A, White F C, Nimmo L E, Bloor C M. Cardiac vasculature and flow during pressure-overload hypertrophy.  Am J Physiol. 1986;  251 H1031-H1037
• 7 Brown M D, Davies M K, Hudlicka O. The effect of long-term bradycardia on heart microvascular supply and performance.  Cell Mol Biol Res. 1994;  40 137-142
• 8 Cheriex E, Hartgens F, Gordijn T, Depuydt K, Keizer H A, Kuipers H. Cardiac dimensions and function are not affected by eight weeks androgenic-anabolic steroid use.  Med Sci Sports Exerc. 1996;  28 S35
• 9 Chilian W M, Wangler R D, Peters K G, Tomanek R J, Marcus M L. Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis.  Circ Res. 1985;  57 591-598
• 10 Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.  Science. 1985;  230 1375-1378
• 11 De Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E. Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function.  Int J Sports Med. 1991;  12 408-412
• 12 Dimauro J, Balnave R J, Shorey C D. Effects of anabolic steroids and high intensity exercise on rat skeletal muscle fibres and capillarization. A morphometric study.  Eur J Appl Physiol. 1992;  64 204-212
• 13 Ferenchick G S, Hirokawa S, Mammen E F, Schwartz K A. Anabolic-androgenic steroid abuse in weight-lifters: evidence for activation of the hemostatic system.  Am J Hematol. 1995;  49 282-288
• 14 Ferreira I M, Verreschi I T, Nery L E, Goldstein R S, Zamel N, Brooks D, Jardim J R. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients.  Chest. 1998;  114 19-28
• 15 Fischer G M, Bashey R I, Rosenbaum H, Lyttle C R. A possible mechanism in arterial wall for mediation of sex difference in atherosclerosis.  Exp Mol Pathol. 1985;  43 288-296
• 16 Fischer M, Appleby M, Rittoo D, Cotter L. Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids.  Br J Clin Pract. 1996;  50 222-223
• 17 Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.  N Engl J Med. 1995;  333 1757-1763
• 18 Folkman J, Ingber D E. Angiostatic steroids. Method of discovery and mechanism of action.  Ann Surg. 1987;  206 374-383
• 19 Folkman J, Langer R, Linhardt R J, Haudenschild C, Taylor S. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.  Science. 1983;  221 719-725
• 20 Franzeck U K, Haselbach P, Speiser D, Bollinger A. Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI).  Yale J Biol Med. 1993;  66 37-46
• 21 Frenzel H, Schwartzkopff B, Holtermann W, Schnurch H G, Novi A, Hort W. Regression of cardiac hypertrophy: morphometric and biochemical studies in rat heart after swimming training.  J Mol Cell Cardiol. 1988;  20 737-751
• 22 Fukuda M, Maekawa J, Hosokawa Y, Urata Y, Sugihara H, Hattori T, Miyoshi N, Nakanishi K, Fujita S. Hormone-dependent changes of blood vessels in DMBA-induced rat mammary carcinoma and its regression studied by 31H-thymidine autoradiography.  Basic Appl Histochem. 1985;  29 21-43
• 23 Gundersen H J. Notes of the estimation of the numerical density of arbitrary profiles.  J Microsc. 1977;  111 219-223
• 24 Hartgens F, Rietjens G, Cheriex E, Wolffenbuttel B HR, Keizer H A, Kuipers H. Effects of an anabolic steroid on cardiovascular risk factors and the left ventricle in bodybuilders.  Med Sci Sports Exerc. 1997;  29 S292
• 25 Hartmann G, Addicks K, Donike M, Schänzer W. Testosterone application influences sympathetic activity on intracardiac nerves in non-trained and trained mice.  J Auton Nerv Syst. 1986;  17 85-100
• 26 Hollmann W. Risikofaktoren in der Entwicklung des Hochleistungssports.  Dtsch Z Sportmed. 1987;  38 36-39
• 27 Holmang A, Svedberg J, Jennische E, Bjorntorp P. Effects of testosterone on muscle insulin sensitivity and morphology in female rats.  Am J Physiol. 1990;  259 E555-E560
• 28 Hudlicka O, Brown M D, Walter H, Weiss J B, Bate A. Factors involved in capillary growth in the heart.  Mol Cell Biochem. 1995;  147 57-68
• 29 Karhunen M K, Ramo M P, Kettunen R. Anabolic steroids alter the haemodynamic effects of endurance training and deconditioning in rats.  Acta Physiol Scand. 1988;  133 297-306
• 30 Kennedy M C, Lawrence C. Anabolic steroid abuse and cardiac death.  Med J Aust. 1993;  158 346-348
• 31 Kennedy M C, O'Sullivan A J. Do anabolic-androgenic steroids enhance sporting performance?.  Med J Aust. 1997;  166 60-61
• 32 Kiiskinen A, Heikkinen E. Physical training and connective tissues in young mice-heart.  Eur J Appl Physiol. 1976;  35 167-171
• 33 Luke J L, Farb A, Virmani R, Sample R H. Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings.  J Forensic Sci. 1990;  35 1441-1447
• 34 Mall G, Zimmer G, Baden S, Mattfeldt T. Capillary neoformation in the rat heart - stereological studies on papillary muscles in hypertrophy and physiologic growth.  Basic Res Cardiol. 1990;  85 531-540
• 35 Mattfeldt T, Kramer K L, Zeitz R, Mall G. Stereology of myocardial hypertrophy induced by physical exercise.  Virchows Arch A Pathol Anat Histopathol. 1986;  409 473-484
• 36 McElroy C L, Gissen S A, Fishbein M C. Exercise-induced reduction in myocardial infarct size after coronary artery occlusion in the rat.  Circulation. 1978;  57 958-962
• 37 Melchert R B, Herron T J, Welder A A. The effect of anabolic-androgenic steroids on primary myocardial cell cultures.  Med Sci Sports Exerc. 1992;  24 206-212
• 38 Muchmore J S, Cooper D K, Ye Y, Schlegel V, Pribil A, Zuhdi N. Prevention of loss of vertebral bone density in heart transplant patients.  J Heart Lung Transplant. 1992;  11 959-963
• 39 Müller R, Hollmann W. Acute influence of an anabolic steroid on lipoproteins of resistance trained athletes.  Dtsch Z Sportmed. 1988;  39 35-40
• 40 Nieminen M S, Ramo M P, Viitasalo M, Heikkila P, Karjalainen J, Mantysaari M, Heikkila J. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters.  Eur Heart J. 1996;  17 1576-1583
• 41 Norrby K, Jacobsson A, Sorbo J. On mast-cell mediated angiogenesis in the rat mesenteric-window assay.  Agents Actions. 1990;  30 231-233
• 42 Petren T. Der Einfluss des Trainings auf die Häufigkeit der Capillaren in Herz- und Skelettmuskulatur.  Arbeitsphysiologie. 1936;  9 376-386
• 43 Rakusan K, Flanagan M F, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy.  Circulation. 1992;  86 38-46
• 44 Rakusan K, Korecky B, Sarkar K, Turek Z. Merits and pitfalls in morphological assessment of cardiac growth.  Fed Proc. 1986;  45 2580-2584
• 45 Sachtleben T R, Berg K E, Elias B A, Cheatham J P, Felix G L, Hofschire P J. The effects of anabolic steroids on myocardial structure and cardiovascular fitness.  Med Sci Sports Exerc. 1993;  25 1240-1245
• 46 Schantz P. Capillary supply in heavy-resistance trained non-postural human skeletal muscle.  Acta Physiol Scand. 1983;  117 153-155
• 47 Schön F A. Licht- und elektronenmikroskopische Befunde am Musculus vastus lateralis und ihr Bezug zu physiologischen Messgrößen bei Normalpersonen, Sportstudenten und Ausdauertrainierten. Dissertation. Deutsche Sporthochschule Köln 1978
• 48 Soares J M, Duarte J A. Effects of training and an anabolic steroid on murine red skeletal muscle. A steroidological analysis.  Acta Anat Basel. 1991;  142 183-187
• 49 Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein M K. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.  JAMA. 1999;  281 1282-1290
• 50 Suzuki H, Takeyama Y, Koba S, Suwa Y, Katagiri T. Small vessel pathology and coronary hemodynamics in patients with microvascular angina.  Int J Cardiol. 1994;  43 139-150
• 51 Tomanek R J. Exercise-induced coronary angiogenesis: a review.  Med Sci Sports Exerc. 1994;  26 1245-1251
• 52 Tomanek R J, Palmer P J, Peiffer G L, Schreiber K L, Eastham C L, Marcus M L. Morphometry of canine coronary arteries, arterioles, and capillaries during hypertension and left ventricular hypertrophy.  Circ Res. 1986;  58 38-46
• 53 Urhausen A, Holpes R, Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids.  Eur J Appl Physiol. 1989;  58 633-640
• 54 Wagner G, Rabkin J, Rabkin R. Exercise as a mediator of psychological and nutritional effects of testosterone therapy in HIV+ men.  Med Sci Sports Exerc. 1998;  30 811-817
• 55 White F C, Witzel G, Breisch E A, Bloor C M, Nimmo L E. Regional capillary and myocyte distribution in normal and exercise trained male and female rat hearts.  Am J Cardiovasc Pathol. 1988;  2 247-253
• 56 Williamson D J. Anabolic steroid use among students at a British college of technology.  Br J Sports Med. 1993;  27 200-201
• 57 Yamamoto T, Terada N, Nishizawa Y, Petrow V. Angiostatic activities of medroxyprogesterone acetate and its analogues.  Int J Cancer. 1994;  56 393-399